PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.
about
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities.Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab.Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative.(99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.Dendrimer-based contrast agents for PET imaging.Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.
P2860
PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PET-based molecular imaging in ...... ssment of therapeutic outcome.
@en
type
label
PET-based molecular imaging in ...... ssment of therapeutic outcome.
@en
prefLabel
PET-based molecular imaging in ...... ssment of therapeutic outcome.
@en
P2860
P356
P1433
P1476
PET-based molecular imaging in ...... ssment of therapeutic outcome.
@en
P2860
P304
P356
10.2217/FON.15.28
P407
P577
2015-01-01T00:00:00Z